Our Leadership
We bring together global leaders and innovators from diverse fields, including universities, pharmaceutical and medical device companies, government agencies, tech firms, the entertainment industry, and people and families with diabetes. Our goal is to champion and advance research to preserve and restore vision in people with diabetes.
Executive Team
S. Robert Levine, MD
Founder and CEO
Jennifer Sun, MD, MPH
MTM Vision Co-Scientific Director, Professor of Ophthalmology, Harvard Medical School
Tom Gardner, MD, MS
MTM Vision Co-Scientific Director, Professor of Ophthalmology & Visual Sciences, Michigan Medicine
Patrice Fort, PhD, MS
Director MTM Vision Biorepository and Resource Center, Michigan Medicine
Eric Carlson
The Carlson Company | Co-Director Media and Cause Marketing
Mark Atkinson, PhD
Chair, External Scientific Advisory Board
Dorene Markel, MS, MHSA
Managing Director
Team Members
Jocelyne Clancy
MTM Vision Consortium Project Manager; Admin Specialist, Caswell Diabetes Institute, Michigan Medicine
Latrice Faulkner, PhD
Administrative Manager, MTM Vision and Program Manager, Caswell Diabetes Institute, Michigan Medicine
Corey Porter, PhD
Technical Manager, MTM Vision Biorepository and Resource Center, Michigan Medicine
Kelli Ramos, BS
Project Manager MTM Vision Biorepository and Resource Center, Michigan Medicine
Shelby Unsworth, PhD
Associate Director for Business Development, Michigan Medicine
Carmen Yu
Research Lab Specialist, MTM Vision Biorepository and Resource Center, Michigan Medicine
Terry Sims
Executive Assistant to Dr. Levine
Lay Advisory Committee
Chris German, PhD
MTM Vision Chair | Senior Scientist, Myriad Genetics | Person with Diabetes
Tom Chapman, MBA
CIO Teewinot Partners | Person with Diabetes
Judy Hunt, MBA
Diabetes Family Advocate
Monica Oxenreiter, MBA, MPP
VP of Close Concerns | Person with Diabetes
Sandra Puczynski, PhD
Diabetes Family Advocate
Adriana Plevniak
Person with Diabetes
External Scientific Advisory Board
Mark Atkinson, PhD
Director of The Diabetes Institute, nPOD and CaRe-TID at The University of Florida
Sally Baxter, MD
UCSD Shiley Eye Institute, Division Chief for Ophthalmology Informatics and Data Science
Dolly Chang, MD, MPH, PhD
Genentech, Senior Medical Director, Research and Early Development
Sanjoy Dutta, PhD
Breakthrough T1D (Formerly JDRF), Chief Scientific Officer
Stephen McLeod, MD
American Academy of Ophthalmology, CEO
Tunde Peto, MD, PhD
Queen’s University Belfast, Professor of Clinical Ophthalmology
Marlon Pragnell, PhD
American Diabetes Association, Vice President of Research and Science
Christopher Rhodes, PhD
AstraZeneca Chief Scientist/Vice President, Cardiovascular, Renal and Metabolic Disease
José Sahel, MD, PhD
University of Pittsburgh School of Medicine, Chair of Ophthalmology
Marie Schiller
Interim CEO, The Diabetes Link
Don Zack, MD, PhD
Co-Director, Johns Hopkins Center for Stem Cells and Ocular Regenerative Medicine
Media and Fund Development Advisors
Red Maxwell
Senior Advisor, Marketing and Communications
Tom Brobson
Senior Advisor, Fund Development, Former JDRF National Director, Research Investment Opportunities
Eric Carlson
The Carlson Company | Co-Director Media and Cause Marketing
Susan Carlson
The Carlson Company | Co-Director Media and Cause Marketing
Nicole Sexton
President and CEO, Entertainment Industry Foundation
Brian Gott
Chief Innovation Officer & Head of Industry Relations for the Entertainment Industry Foundation
About Diabetic Retinal Disease
Diabetic Retinal Disease is the number one cause of blindness in working-age adults worldwide.
Learn MoreOur Partners
With our partners we are helping to preserve and restore vision in people with diabetes.
Learn MoreJoin Our Email List
By submitting this form, you are consenting to receive marketing emails from: Mary Tyler Moore Vision Initiative. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact